Arecor Therapeutics (AREC)

Sector:

Pharma and Biotech

Index:

FTSE AIM All-Share

 76.50p
   
  • Change Today:
      0.000p
  • 52 Week High: 199.00p
  • 52 Week Low: 66.00p
  • Currency: UK Pounds
  • Shares Issued: 37.76m
  • Volume: 413
  • Market Cap: £28.88m
  • Beta: 0.09

AREC Overview

Arecor is a globally focused biopharmaceutical company that is targeting improving patient care by bringing innovative medicines to market through the enhancement of existing therapeutic products. By applying the Group's innovative proprietary formulation technology platform, Arestat™, the Group is developing an internal portfolio of proprietary products, as well as working with pharmaceutical and biotechnology companies to deliver enhanced reformulations of their partners' therapeutic products, supported by an extensive patent portfolio.

1 Day Chart

1 Day Chart

6 Month Chart

6 Month Chart
Barclays logo

Digital Look Charts Sponsored by Barclays Stockbrokers

Financials

Latest F'cast
Div Yield 0.0% 0.0%
Div Cover n/a n/a
Op Mrgn -200.6% n/a
ROCE n/a  
Latest F'cast
P/E n/a n/a
PEG n/a n/a
Pr/Revenue 6.3 n/a
Pr/Book 3.0  
Latest F'cast
Revenue 90.3% n/a
PBT n/a n/a
EPS n/a n/a
DPS n/a n/a

AREC Fundamentals

Year Ending Revenue (£m) Pre-tax (£m) EPS P/E PEG EPS Grth. Div Yield
31-Dec-20 1.70 (3.51) (17.00)p n/a n/a n/a n/a 0.0%
31-Dec-21 1.16 (6.95) (27.00)p n/a n/a n/a n/a 0.0%
31-Dec-22 2.40 (10.54) (32.00)p n/a n/a n/a n/a 0.0%
31-Dec-23 4.57 (8.90) (28.00)p n/a n/a n/a n/a 0.0%

a. Based on UK GAAP presentation of accounts - includes discontinued activities

AREC Company Announcements

Arecor Appoints Interim Chief Financial Officer 18-Nov-2024 07:00 RNS
Interim Results for six months ended 30 June 2024 26-Sep-2024 07:00 RNS
Notice of Results 19-Sep-2024 15:17 RNS

AREC ShareCast News

Arecor Therapeutics shares tank on funding update 10-Jun-2024 ShareCast
Arecor subsidiary Tetris launching Ogluo in the ... 29-Feb-2024 ShareCast
Arecor appoints new commercial manager to Tetris... 03-Jan-2024 ShareCast

Latest AREC Director Deals

No deals were found in the last 28 days.

Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

Note 2: Above ratios are on a 'per annum' basis, adjusted for corporate actions and based on the fundamentals of the primary listed security.

Note 3: Under IFRS, all figures are based on 'Continuing' operations unless otherwise stated.

Note 4: In the case of dual listed securities, broker recommendations and forecasts relate to the primary listing.

Note 5: Forecast figures based on normalised accounts.

 

AREC Market Data

Currency UK Pounds
Share Price 76.50p
Change Today 0.000p
% Change 0.00 %
52 Week High 199.00p
52 Week Low 66.00p
Volume 413
Shares Issued 37.76m
Market Cap £28.88m
Beta 0.09

AREC Star Ratings

Compare performance with the sector and the market.
more star ratings
Key: vs Market vs Sector
Value
53.6% below the market average53.6% below the market average53.6% below the market average53.6% below the market average53.6% below the market average
Sector averageSector averageSector averageSector averageSector average
Price Trend
87.11% below the market average87.11% below the market average87.11% below the market average87.11% below the market average87.11% below the market average
71.43% below the sector average71.43% below the sector average71.43% below the sector average71.43% below the sector average71.43% below the sector average
Income Not Available
Growth
59.12% above the market average59.12% above the market average59.12% above the market average59.12% above the market average59.12% above the market average
64.71% above the sector average64.71% above the sector average64.71% above the sector average64.71% above the sector average64.71% above the sector average

AREC Dividends

No dividends found

Trades for 21-Nov-2024

Time Volume / Share Price
11:00 392 @ 73.50p
11:00 392 @ 73.50p
09:00 20 @ 73.50p
09:00 20 @ 73.50p
08:15 1 @ 78.00p

AREC Key Personnel

CEO Sarah Jennifer Howell
CFO David Ellam

Top of Page